{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:52:31Z","timestamp":1792119151513,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1991,12,1]],"date-time":"1991-12-01T00:00:00Z","timestamp":691545600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psych Quart"],"published-print":{"date-parts":[[1991,12]]},"DOI":"10.1007\/bf01958798","type":"journal-article","created":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T13:37:02Z","timestamp":1122903422000},"page":"299-309","source":"Crossref","is-referenced-by-count":29,"title":["Neuroleptic malignant syndrome: A complication of neuroleptics and cocaine abuse"],"prefix":"10.1007","volume":"62","author":[{"given":"MaCaulay J.","family":"Akpaffiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF01958798_CR1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0447.1986.tb02694.x","volume":"73","author":"A Shalev","year":"1986","unstructured":"Shalev A, Munitz H: The Neuroleptic malignant syndrome: Agent and host interaction. Acta Psychiatrica Scandinavica; 73: 37\u2013347, 1986.","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"BF01958798_CR2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJM198507183130306","volume":"313","author":"BH Guze","year":"1985","unstructured":"Guze BH, Baxter, LR: Current concepts neuroleptic malignant syndrome. New England Journal of Medicine 313: 163\u2013166. 1985.","journal-title":"New England Journal of Medicine"},{"key":"BF01958798_CR3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00002826-198406000-00001","volume":"7","author":"R Kurlan","year":"1984","unstructured":"Kurlan R, Hamil R, Shoulson I: Neuroleptic malignant syndrome. Clinical neuropharmacology, 7: 109\u2013120, 1984.","journal-title":"Clinical neuropharmacology"},{"key":"BF01958798_CR4","first-page":"79","volume":"41","author":"SN Caroff","year":"1980","unstructured":"Caroff SN: Neuroleptic malignant syndrome. Journal of Clinical Psychiatry 41: 79\u201383, 1980.","journal-title":"Journal of Clinical Psychiatry"},{"key":"BF01958798_CR5","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1176\/ajp.143.12.1587","volume":"143","author":"A Addonizio","year":"1986","unstructured":"Addonizio A, Susman VL, Roth SD: Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. American Journal of Psychiatry 143: 1587\u20131590, 1986.","journal-title":"American Journal of Psychiatry"},{"key":"BF01958798_CR6","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1176\/ajp.144.10.1344","volume":"144","author":"PE Keck","year":"1987","unstructured":"Keck PE, Pope HG, McElroy SL: Frequency and presentation of neuroleptic malignant syndrome: A prospective study. American Journal of Psychiatry 144: 1344\u20131346, 1987.","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"BF01958798_CR7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/00952998809001555","volume":"14","author":"TR Kosten","year":"1988","unstructured":"Kosten TR, Kleber HD: Rapid death during Cocaine abuse: A variant of the neuroleptic malignant syndrome? American Journal of Drug Alcohol Abuse 14(3): 335\u2013346, 1988.","journal-title":"American Journal of Drug Alcohol Abuse"},{"key":"BF01958798_CR8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archpsyc.1986.01800090025005","volume":"43","author":"DF Levinson","year":"1986","unstructured":"Levinson DF, Simpson GM: Neuroleptic-induced extrapyramidal symptoms with fever. Archives of General Psychiatry 43: 839\u2013848, 1986.","journal-title":"Archives of General Psychiatry"},{"key":"BF01958798_CR9","first-page":"383","volume":"227","author":"S Yamawaki","year":"1983","unstructured":"Yamawaki S, Lai H, Horita A: Dopaminergic and serotonergic mechanisms of thermoregulation: Mediation of thermal effects of apomorphine and dopamine. Journal of Pharmacology and Experimental Therapeutics 227: 383\u2013388, 1983.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF01958798_CR10","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJM197912133012403","volume":"301","author":"TA McLellan","year":"1979","unstructured":"McLellan TA, Woody SE, O'Brien CP: Development of Psychiatric Illness in Drug Abusers. New England Journal Medicine 301: 1310\u20131314, 1979.","journal-title":"New England Journal Medicine"},{"key":"BF01958798_CR11","first-page":"26","volume":"52","author":"JM Cleghorn","year":"1991","unstructured":"Cleghorn JM, Kaplan RD, Szechtman B: Substance abuse and schizophrenia: Effect on symptoms but not on neurocognitive function. Journal of Clinical Psychiatry 52: 26\u201330, 1991.","journal-title":"Journal of Clinical Psychiatry"},{"key":"BF01958798_CR12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1176\/ajp.143.10.1227","volume":"143","author":"HG Pope","year":"1986","unstructured":"Pope HG, Keck PE, McElroy SL: Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. American Journal of Psychiatry, 143: 1227\u20131233, 1986.","journal-title":"American Journal of Psychiatry"},{"key":"BF01958798_CR13","first-page":"1441","volume":"18","author":"TY Lew","year":"1983","unstructured":"Lew TY, Tollefson G: Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam. Biological Psychiatry 18: 1441\u20131446, 1983.","journal-title":"Biological Psychiatry"},{"key":"BF01958798_CR14","first-page":"559","volume":"31","author":"H Itoh","year":"1977","unstructured":"Itoh H, Ohtsuka N, Ogitak K, Yagi G, Miura S and Koga Y: Malignant neuroleptic syndrome\u2014Its present status in Japan and clinical problems. Folia Psychiatry et Neurologic Japanica 31: 559\u2013576, 1977.","journal-title":"Folia Psychiatry et Neurologic Japanica"},{"key":"BF01958798_CR15","first-page":"99","volume":"40","author":"L Grunhaus","year":"1979","unstructured":"Grunhaus L, Sancovici S, Rimon R: Neuroleptic malignant syndrome due to depot fluphenazine. Journal of Clinical Psychiatry 40: 99\u2013100, 1979.","journal-title":"Journal of Clinical Psychiatry"},{"key":"BF01958798_CR16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.31.2.132","volume":"31","author":"VW Henderson","year":"1981","unstructured":"Henderson VW, Wooten GF: Neuroleptic malignant syndrome: A pathogenetic role for dopamine receptor blockade? Neurology (Ng) 31: 132\u2013137, 1981.","journal-title":"Neurology (Ng)"},{"key":"BF01958798_CR17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1213\/00000539-198309000-00014","volume":"62","author":"S Weinberg","year":"1983","unstructured":"Weinberg S, Twersky RS: Neuroleptic malignant syndrome. Anesthesia Analgesia 62: 848\u2013850, 1983.","journal-title":"Anesthesia Analgesia"},{"key":"BF01958798_CR18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1113\/jphysiol.1979.sp012886","volume":"293","author":"MT Lin","year":"1979","unstructured":"Lin MT: Effects of dopaminergic antagonist and agonist on thermoregulation in rabbits. Journal of Physiology 293: 217\u2013228, 1979.","journal-title":"Journal of Physiology"},{"key":"BF01958798_CR19","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.31.8.1022","volume":"31","author":"R Burke","year":"1981","unstructured":"Burke R, Fahn S, Mayeux R, Weinberg H, Louis K, Willner JH: Neuroleptic malignant syndrome caused by dopamine depleting agents in a patient with Huntington's disease. Neurology 31: 1022\u20131026, 1981.","journal-title":"Neurology"},{"key":"BF01958798_CR20","first-page":"797","volume-title":"Psychopharmacology: A generation of Progress","author":"AJ Friedhoff","year":"1978","unstructured":"Friedhoff AJ, Alpert M: Receptor sensitivity modification as a potential treatment. In: Lipton MA, Dimuscio A, Killam KF, eds, Psychopharmacology: A generation of Progress, New York, New York: Raven Press 797\u2013801, 1978."},{"key":"BF01958798_CR21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/jnr.490030203","volume":"3","author":"D Taylor","year":"1977","unstructured":"Taylor D, Ho BT: Neurochemical effects of cocaine following acute and repeated injection. Journal of Neuroscience Research 3: 95\u2013101, 1977.","journal-title":"Journal of Neuroscience Research"},{"key":"BF01958798_CR22","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0028-3908(81)90055-1","volume":"20","author":"M Memo","year":"1981","unstructured":"Memo M, Pradham S, Hanbauer I: Cocaine induced supersensitivity of striatal dopamine receptors: Role of endogenous calmodulin. Neuropharmacology 20: 1145\u20131150, 1981.","journal-title":"Neuropharmacology"},{"key":"BF01958798_CR23","first-page":"1323","volume-title":"Psychopharmacology: A Generation of Progress","author":"RM Post","year":"1978","unstructured":"Post RM, Frontier in Affective Disorder Research: New pharmacological agents and new methodologies. In: Lipton MA, DiMascio A, Killam KF, (eds). Psychopharmacology: A Generation of Progress. New York, Raven Press 1323\u20131335, 1978."},{"key":"BF01958798_CR24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(81)90504-5","volume":"76","author":"W Memon","year":"1981","unstructured":"Memon W, Vivonia CA: Modification of apomorphine hypothermia by drugs affecting brain 5 hydroxytryptamine function. European Journal of Pharmacology 76: 223\u2013227, 1981.","journal-title":"European Journal of Pharmacology"},{"key":"BF01958798_CR25","first-page":"321","volume-title":"Proceedings of the 5th collequim international neuropsychopharmacologicum","author":"Rossum Van","year":"1967","unstructured":"Van Rossum: The significance of dopamine-receptor blockade for the action of neuroleptic drugs. In: Brill H, Cole JO, Deniker P, Hippius H, Bradley PB, (eds). Proceedings of the 5th collequim international neuropsychopharmacologicum. Excerpta medica foundation, Amsterdam 321\u2013329, 1967."}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01958798.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01958798\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01958798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T13:30:37Z","timestamp":1557754237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01958798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,12]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1991,12]]}},"alternative-id":["BF01958798"],"URL":"https:\/\/doi.org\/10.1007\/bf01958798","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"value":"0033-2720","type":"print"},{"value":"1573-6709","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,12]]}}}